Home » Denmark » Page 2

Denmark

Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND

Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …

Read more

CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 22 September 2022

Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” Chair: Good Morning (reminder of guidelines) UNODC Research and Analysis Branch, …

Read more

Committee of the Whole (Thursday morning) L4. Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use

EC77/2020/L4   Belgium:There are some paras where the wording is ‘non-stigma’. A couple of paras have been agreed in informals pending on the solution of non-stigmatisation. Chair: Canada was the state proposing language on stigma Canada: If we are going to focus on PPs first we did have discussions during informals. Linking PP that references stigma …

Read more